| Followers | 35 |
| Posts | 2237 |
| Boards Moderated | 0 |
| Alias Born | 10/18/2019 |
Sunday, May 02, 2021 6:09:32 PM
Ex, imo there is a reasonable chance for at least 1 agency (or more) to approve by end of 2022. IF nwbo can get the paper published and tld data out by end of June and then hire a consultant that works quicker than what we saw on the SAP then imo may be able to file bla by end of 2021. Once with the agencies (assuming the bla is accepted without having to do revisions) then 6 to 10 months to potential approval. So yes imo it is possible. Now if may and June go by with no substantial progress then imo you may be correct.
I'm certainly hoping for better but the nwbo track record has not been stellar.
If nothing by June then I will probably move on at least with a good portion of my holdings. I hope it does not come to that.
Last September with statements from LP and LG followed up with really little to no explanation has really left me wondering. We all talk about this 'quiet period' but where is the official company statement to that effect - other than calls to DI?
Hope for May and June to bring much good news. Change the world for both patients and shareholders
I'm certainly hoping for better but the nwbo track record has not been stellar.
If nothing by June then I will probably move on at least with a good portion of my holdings. I hope it does not come to that.
Last September with statements from LP and LG followed up with really little to no explanation has really left me wondering. We all talk about this 'quiet period' but where is the official company statement to that effect - other than calls to DI?
Hope for May and June to bring much good news. Change the world for both patients and shareholders
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
